Literature DB >> 1151111

Epidermolysis bullosa dystrophica-recessive: a possible role of anchoring fibrils in the pathogenesis.

R A Briggaman, C E Wheeler.   

Abstract

The purpose of this study was to define the ultrastructural defects and pathogenesis of epidermolysis bullosa dystrophica-recessive (EBD-R). The only consistent ultrastructural alteration found in EBD-R was an absence of anchoring fibrils. In many specimens of nonblistered, nontraumatized EBD-R skin, absence of anchoring fibrils was the only ultrastructural abnormality observed. The possibility that lack of anchoring fibrils was a secondary change resulting from previous blistering and scarring was eliminated by our observation that anchoring fibrils were consistently absent in the never previously blistered skin of two newborns with EBD-R. In experimentally traumatized skin, the epidermis and dermis separated in the region of the epidermal-dermal junction normally occupied by anchoring fibrils. Basal lamina and dermal microfibril bundles appeared to be normal. Using recombinant grafts, we demonstrated that anchoring fibrils were not formed by EBD-R dermis when combined with EBD-R epidermis or normal epidermis. Anchoring fibrils were formed when normal dermis was combined with normal and EBD-R epidermis. These studies indicate that the defect in EBD-R resides in the dermis and that the defect may be associated with impaired formation of anchoring fibrils.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1151111     DOI: 10.1111/1523-1747.ep12598208

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  20 in total

1.  Epidermolysis bullosa dystrophica: abnormal numbers of lysosomes in cultured fibroblasts.

Authors:  M W Kanan; T J Ryan; M J Francis; B C Sykes; W B Reed
Journal:  J Inherit Metab Dis       Date:  1978       Impact factor: 4.982

2.  Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene.

Authors:  A Hovnanian; P Duquesnoy; C Blanchet-Bardon; R G Knowlton; S Amselem; M Lathrop; L Dubertret; J Uitto; M Goossens
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

3.  Epidermolysis bullosa dystorphica and systemic lupus erythematosus.

Authors:  G C Archibald
Journal:  Proc R Soc Med       Date:  1976-12

Review 4.  Epidermolysis bullosa: hereditary skin fragility diseases as paradigms in cell biology.

Authors:  R A Eady; M G Dunnill
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  Ultrastructural studies in epidermolysis bullosa hereditaria. II. Dominant dystrophic type of Cockayne and Touraine.

Authors:  I Hashimoto; T Gedde-Dahl; U W Schnyder; I Anton-Lamprecht
Journal:  Arch Dermatol Res       Date:  1976-06-21       Impact factor: 3.017

6.  The fate of hemidesmosomes in laryngeal carcinoma.

Authors:  P Schenk
Journal:  Arch Otorhinolaryngol       Date:  1979

7.  Genetic linkage to the type VII collagen gene (COL7A1) in 26 families with generalised recessive dystrophic epidermolysis bullosa and anchoring fibril abnormalities.

Authors:  M G Dunnill; A J Richards; G Milana; F Mollica; D Atherton; I Winship; M Farrall; L al-Imara; R A Eady; F M Pope
Journal:  J Med Genet       Date:  1994-10       Impact factor: 6.318

8.  Ultrastructural studies in epidermolysis bullosa hereditaria. III. Recessive dystrophic types with dermolytic blistering (Hallopeau-Siemens types and inverse type).

Authors:  I Hashimoto; U W Schnyder; I Anton-Lamprecht; T Gedde-Dahl; S Ward
Journal:  Arch Dermatol Res       Date:  1976-08-27       Impact factor: 3.017

9.  Esophageal involvement in epidermolysis bullosa dystrophica: clinical and roentgenographic manifestations.

Authors:  F P Agha; I R Francis; C N Ellis
Journal:  Gastrointest Radiol       Date:  1983

10.  Exclusion of linkage between the collagenase gene and generalized recessive dystrophic epidermolysis bullosa phenotype.

Authors:  A Hovnanian; P Duquesnoy; S Amselem; C Blanchet-Bardon; M Lathrop; L Dubertret; M Goossens
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.